EdgarLookup

Addex Therapeutics Ltd. — SC 13D/A Filings

14 SC 13D/A filings on record

This page lists all SC 13D/A filings submitted to the SEC by Addex Therapeutics Ltd. (ADXN), sorted by most recent first. Each row links to the full filing on EdgarLookup. Addex Therapeutics Ltd. has filed 14 SC 13D/A documents with the SEC since 2019. To view all SEC filings by Addex Therapeutics Ltd., see the full filings list.

Overview All Filings Financials Insiders
All 20-F 3 424B3 424B4 424B5 6-K 6-K/A 8-A12B CERT CORRESP D DEL AM DRS DRS/A DRSLTR EFFECT F-1 F-1/A F-3 NT 20-F POS AM S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#7E) 0001072613-24-000634 Aug 14, 2024
SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#6) 0001072613-24-000602 Aug 5, 2024
SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#5) 0001072613-23-000611 Dec 8, 2023
SC 13D/A SC 13D/A 0001104659-23-122019 Nov 29, 2023
SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#4) 0001072613-23-000298 Apr 10, 2023
SC 13D/A SC 13D/A 0001104659-23-042133 Apr 5, 2023
SC 13D/A SC 13D/A 0001104659-23-040143 Mar 31, 2023
SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A3 0001072613-22-000649 Nov 28, 2022
SC 13D/A SC 13D/A 0001104659-22-121418 Nov 23, 2022
SC 13D/A SC 13D/A 0001104659-22-116458 Nov 9, 2022
SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A2 0001072613-22-000523 Aug 23, 2022
SC 13D/A SC 13D/A 0001104659-22-086368 Aug 5, 2022
SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13DA1 0001072613-22-000026 Jan 10, 2022
SC 13D/A SC 13D/A 0001104659-21-113568 Sep 8, 2021